Ирина Якутенко - Вирус, который сломал планету. Почему SARS-CoV-2 такой особенный и что нам с ним делать

C. Cervia et al. , «Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19», bioRxiv , p. 2020.05.21.108308, Jan. 2020.

N. Le Bert et al. , «SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls», Nature , vol. 584, no. 7821, pp. 457–462, Aug. 2020.

J. Braun et al. , «SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19», Nature , Jul. 2020.

E. Kudo et al. , «Low ambient humidity impairs barrier function and innate resistance against influenza infection», Proc. Natl. Acad. Sci. , vol. 116, no. 22, pp. 10905–10910, May 2019.

D. P. Oran and E. J. Topol, «Prevalence of Asymptomatic SARS-CoV-2 Infection», Ann. Intern. Med. , pp. M20–3012, Jun. 2020.

Q.-X. Long et al. , «Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections», Nat. Med. , Jun. 2020.

K. K.-W. To et al. , «COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing», Clin. Infect. Dis. , Aug. 2020.

A. Woodward and H. Brueck, «2 more people have been reinfected with the coronavirus, European scientists say, a day after the first confirmed reinfection in Hong Kong», Business Insider , 25-Aug-2020.

C. Weemaes, I. Klasen, J. Goertz, M. Beldhuis-Valkis, O. Olafsson, and A. Haraldsson, «Development of Immunoglobulin A in Infancy and Childhood», Scand. J. Immunol. , vol. 58, no. 6, pp. 642–648, Dec. 2003.

K. W. Leong and J. L. Ding, «The Unexplored Roles of Human Serum IgA», DNA Cell Biol. , vol. 33, no. 12, pp. 823–829, Dec. 2014.

K. Chen et al. , «Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell — stimulating programs in basophils», Nat. Immunol. , vol. 10, no. 8, pp. 889–898, Aug. 2009.

T. Sekine et al. , «Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19», bioRxiv , p. 2020.06.29.174888, Jan. 2020.

T. Sekine et al. , «Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19», Cell , Aug. 2020.

F. Wu et al. , «Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications», medRxiv , p. 2020.03.30.20047365, Jan. 2020.

Q.-X. Long et al. , «Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections», Nat. Med. , Jun. 2020.

Q. Ye, B. Wang, and J. Mao, «The pathogenesis and treatment of the `Cytokine Storm’ in COVID-19», J. Infect. , vol. 80, no. 6, pp. 607–613, Jun. 2020.

X. Cao, «COVID-19: immunopathology and its implications for therapy», Nat. Rev. Immunol. , vol. 20, no. 5, pp. 269–270, May 2020.

N. Mangalmurti and C. A. Hunter, «Cytokine Storms: Understanding COVID-19», Immunity , vol. 53, no. 1, pp. 19–25, Jul. 2020.

D. Blanco-Melo et al. , «Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19», Cell , May 2020.

Y. Konno et al. , «SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is further increased by a naturally occurring elongation variant», bioRxiv , p. 2020.05.11.088179, Jan. 2020.

Там же.

D. Mercatelli and F. M. Giorgi, «Geographic and Genomic Distribution of SARS-CoV-2 Mutations», Front. Microbiol. , vol. 11, Jul. 2020.

K. G. Lokugamage, A. Hage, C. Schindewolf, R. Rajsbaum, and V. D. Menachery, «SARS-CoV-2 is sensitive to type I interferon pretreatment», bioRxiv , p. 2020.03.07.982264, Jan. 2020.

«Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection», ClinicalTrials.gov , 2020.

X. Yang et al. , «Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study», Lancet Respir. Med. , vol. 8, no. 5, pp. 475–481, May 2020.

V. O. Puntmann et al. , «Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)», JAMA Cardiol. , Jul. 2020.

A. Cuker and F. Peyvandi, «Coronavirus disease 2019 (COVID-19): Hypercoagulability», UpToDate , 20-Aug-2020.

H. Moldofsky and J. Patcai, «Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study», BMC Neurol. , vol. 11, no. 1, p. 37, Dec. 2011.

H. W. Wilson, M. Amo-Addae, E. Kenu, O. S. Ilesanmi, D. K. Ameme, and S. O. Sackey, «Post-Ebola Syndrome among Ebola Virus Disease Survivors in Montserrado County, Liberia 2016», Biomed Res. Int. , vol. 2018, pp. 1–8, Jun. 2018.

T. Yang et al. , «The clinical value of cytokines in chronic fatigue syndrome», J. Transl. Med. , vol. 17, no. 1, p. 213, Dec. 2019.

M. W. Tenforde et al. , «Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March — June 2020», MMWR. Morb. Mortal. Wkly. Rep. , vol. 69, no. 30, pp. 993–998, Jul. 2020.

European Centre for Disease Prevention and Control, «Coronavirus disease 2019 (COVID-19)in the EU/EEA and the UK — eighth update», 2020.

Z. Wu and J. M. McGoogan, «Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China», JAMA , vol. 323, no. 13, p. 1239, Apr. 2020.

Istituto Superiore di Sanità, «Characteristics of SARS-CoV-2 patients dying in Italy. Report based on available data on May 21st, 2020», 2020.

A. C. Fabrizio, Natale, Daniela Ghio, Dario Tarchi, Anne Goujon, «COVID-19 Cases and Case Fatality Rate by age», 2020.

F. Perrotta et al. , «COVID-19 and the elderly: insights into pathogenesis and clinical decision-making», Aging Clin. Exp. Res. , Jun. 2020.

M. Zheng et al. , «Functional exhaustion of antiviral lymphocytes in COVID-19 patients», Cell. Mol. Immunol. , vol. 17, no. 5, pp. 533–535, May 2020.

K. Úri et al. , «New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) IV: Circulating ACE2 as a Biomarker of Systolic Dysfunction in Human Hypertension and Heart Failure», PLoS One , vol. 9, no. 4, p. e87845, Apr. 2014.